Project Grant R01AG085308
Award Date
8/15/24
Completion Date
4/30/29
Dollars Obligated
$721K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $405,849 will fund research at Keck Graduate Institute of Applied Life Sciences in Claremont, CA to investigate the impact of obesity-induced liver dysfunction on the development of Alzheimer's disease pathology. The key objectives are to: 1) Examine how obesity-driven changes in liver amyloid-beta processing and clearance affect brain amyloid levels and Alzheimer's disease markers in...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) provides $660,402 to the University of Maryland, Baltimore (UMB) to study the role of autophagy, a cellular process that recycles damaged components, in regulating lipid metabolism and inflammation in microglia during brain aging and neurodegenerative diseases like Alzheimer's disease (AD). The research aims to determine how microglial lipid phagocytosis inhibits autophagy, leading to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $783,003 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to investigate the role of oxidative stress and microglial dysfunction in Alzheimer's disease. The research aims to elucidate the molecular mechanisms by which oxidation disrupts microglial phagocytosis, leading to detrimental consequences in Alzheimer's. The project will develop new interventions...
This $249,000 project grant, awarded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to investigate the mechanisms by which midlife obesity and prediabetes contribute to later-life cognitive decline and Alzheimer's disease-related dementias (AD/ADRD). The key objectives are to:
Establish the role of the cGAS/STING inflammatory pathway and the broader inflammatory milieu during the progression from midlife obesity and prediabetes to later-life...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,400 to Nova Southeastern University to evaluate the therapeutic potential of three compounds - tirzepatide, retatrutide, and crocetin - in mitigating Alzheimer's-like pathology in a mouse model of comorbid Alzheimer's disease and obesity/prediabetes. The 3-year project, running from December 2024 to November 2027, will assess the compounds' impact on cognitive-behavioral function,...
This Project Grant award for $245,040 from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research study at Yale University to investigate the relationship between neuronal and astrocytic dysfunction, cerebral metabolism, and vascular health in the context of Alzheimer's disease (AD) pathogenesis. The key objectives are to:
Behaviorally monitor the development of AD to determine disease onset.
Map deficits in neuronal/astrocytic function in relation to...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to investigate the role of O-GlcNAcylation in regulating astrocytic mitochondrial function and neuroinflammation in an Alzheimer's disease mouse model. The $406,817 award to the University of Alabama at Birmingham (UAB) will explore how changes in this post-translational protein modification impact mitochondrial dysfunction and neuroinflammation, which are key pathogenic...
This Project Grant award of $812,030 from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) aims to develop and optimize noninvasive imaging biomarkers to track neuroinflammation in the early stages of Alzheimer's disease (AD). The key research activities include:
Investigating the relationship between astrocytic acetate metabolism and astrocyte reactivity in an adenovirus-induced reactive astrogliosis model, using deuterium-magnetic-resonance-spectroscopy...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $805,738 to the Battelle Memorial Institute's Pacific Northwest National Laboratory to conduct research on the impact of brain lipoprotein structure and composition on amyloid beta metabolism and Alzheimer's disease. The key objectives are to: 1) Assess how APOE isoforms affect brain lipoprotein distribution, composition, and ability to bind amyloid beta, and 2) Determine the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $4,151,128 to The Winifred Masterson Burke Medical Research Institute, Inc. to investigate the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the pathogenesis of Alzheimer's disease. The 5-year project, which began on September 1, 2024, aims to elucidate how modifications in brain activity, particularly in the locus coeruleus and hippocampus, can lead to...